BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona.

from Combined News for Reuters & Al Jazeera copy http://ift.tt/1uf5ZiY
from Combined News for Reuters & Al Jazeera copy http://ift.tt/1uf5ZiY
0 commentaires:
Enregistrer un commentaire